Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Xtremepicks Alerts Message Board

$NVGT huge recent news! Novagant, Inc. Enters Pote

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 89344
Posted On: 06/30/2014 9:38:36 AM
Avatar
Posted By: BCNstocks
$NVGT huge recent news! Novagant, Inc. Enters Potential $8.4 Billion Medical Cannabis Industry With an All Legal Medical "Hemp" Cannabis Vaporizer >>

http://www.marketwired.com/press-release/nova...924298.htm

DENVER, CO--(Marketwired - June 25, 2014) - Novagant, Inc. (PINKSHEETS: NVGT) is pleased to announce its new medical cannabis vaporizer product, GLAVape™ (Generally Legal American Vape), which is the finest and most consistent Cannabidiol (CBD)-rich hemp oil in the world.

Hemp is available over the counter (OTC) in all 50 States and over 40 Countries. It is not marijuana and does not require a medical marijuana license for purchase. Although both hemp and marijuana are in the same cannabis family of plants, they are vastly different from a legal perspective.

Cannabidiol is looked for its "potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders." (http://www.projectcbd.org/about/introducing-cbd/)

According to an IBISWorld report, and as reported by The Street, the medical marijuana industry is expected to grow 63% in 2014, and reach $8.4 Billion in revenues by 2019. (http://www.thestreet.com/video/12747902/medical-marijuana-industry-revenue-could-reach-84-billion.html)

The Company's GLAVape™ is 100% natural and derived from the federally-legal industrial hemp plant. The Company's unique hemp cultivars, combined with its proprietary technologies, produce the highest quality CBD-rich hemp oil in the world.

GLAVape™ is lab tested multiple times during the manufacturing process, from seed to shelf. The Company tests for CBD content, other cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and quality.

Other features of the GLAVape™ are:

• Natural Organic (non-synthetic), safe, legal product.
• Non-psychoactive.
• 10% CBD+ by volume.
• Decarboxylated and filtered.
• Made from Hemp Oil (Seed & Stalk).
• Is from non-GMO industrial hemp grown without pesticides, herbicides, or chemical fertilizers.
• Is stringently lab tested for quality.
• Is fully insured and independently certified.

The GLAVape™ Pen is available in 0.3ml, 0.6ml, and 1.0ml and sizes.
Wholesalers in need of bulk quantities of GLAVape™ can contact a representative from Novagant, Inc. for wholesales pricing.
About Novagant, Inc.

Novagant, Inc. was incorporated in the state of Nevada on February 23, 1987 under the name of Kendrex Systems, Inc. The Company underwent several name changes, and ultimately on November 26, 2013 changed its name to Novagant, Inc. For more information about the Company, please visit http://www.novagant.com/

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact Information

Contact:
Novagant, Inc.
office@novagant.com



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us